Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -12.48EBIT per Share
VS
Market
Sector
Industry
History
$ 2.86Close
$ 1.42 - $ 24.24 52-Week Range
Ticker Information
Ticker
XFORCompany Name
X4 PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQX4 PHARMACEUTICALS INC - EBIT per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
XFOR - EBITPS Historical data
| Date | Earning Before Interest & Taxes (EBIT) | EBIT per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -92.48M | $ -12.48 | 1 | 7.41M |
| 3/31/2025 | $ 24.02M | $ 3.51 | 1 | 6.84M |
| 12/31/2024 | $ -28.37M | $ -4.23 | 1 | 6.7M |
| 9/30/2024 | $ -8.32M | $ -1.24 | 1 | 6.7M |
| 6/30/2024 | $ 25.3M | $ 3.79 | 1 | 6.68M |
| 3/31/2024 | $ -122.28M | $ -18.34 | 1 | 6.67M |
| 12/31/2023 | $ -95.31M | $ -16.08 | 1 | 5.93M |
| 9/30/2023 | $ -106.05M | $ -16.15 | 1 | 6.57M |
| 6/30/2023 | $ -125.98M | $ -22.4 | 1 | 5.62M |
| 3/31/2023 | $ -91.72M | $ -18.85 | 1 | 4.87M |
Key Performance Insights, Last 5 Years
- X4 PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBITPS stands at $ -77.53.
- Over the past 5 years, X4 PHARMACEUTICALS INC's average EBITPS has been $ -42.85.
- The median EBITPS for X4 PHARMACEUTICALS INC during this period was $ -27.64
- X4 PHARMACEUTICALS INC reached its highest EBITPS over the past 5 years at $ 3.79.
- The lowest EBITPS recorded by X4 PHARMACEUTICALS INC in the same timeframe $ -99.08
X4 PHARMACEUTICALS INC's EBITPS vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITPS Benchmarks
Similar metrics to Shares WA:
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBIT per Share
[Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBIT / (Shares WA * Share Factor)
(=) EBITPS EBITPS for X4 PHARMACEUTICALS INC is calculated as follows: EBIT [ $ -51.9M ] / (Shares WA [ 669.5K ] * Share Factor [ 1 ])
(=) EBITPS [ $ -77.53 ] XFOR - EBIT per Share, Last 5 years
$ -99.08
Minimum
Dec 31, 2021
$ 3.79
Maximum
Jun 30, 2024
$ -42.85
Average
$ -27.64
Median
EBITPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITPS for companies in the Total Stock Market. The average EBITPS of the companies is $ 1.16 with a standard deviation of $ 3.42.
The following table provides additional summary stats:
EBITPS in the Market:
| filtered constituents | 3.79K |
|---|---|
| min | $ -9.72 |
| max | $ 10.76 |
| average | $ 1.16 |
| median | $ 0.38 |
| std | $ 3.42 |